WASHINGTON, D.C. — Paramount Pictures has officially greenlit the third installment of the horror franchise "Smile," appointing David Bruckner to direct and screenwriter Nick Antosca to pen the script. This personnel shift marks a significant structural change for the studio’s supernatural horror portfolio, signaling a strategic pivot in how the company manages high-concept intellectual property. The move aims to sustain audience engagement while allowing the original creator, Parker Finn, to transition into a producer role under Temple Hill.

Bruckner, known for his work on "The Guest" and the anthology series "The Black Phone," was selected for his ability to balance visceral intensity with atmospheric dread. Antosca, a frequent collaborator of Bruckner’s, will develop the narrative framework that Finn initially pitched for the third entry. According to industry sources, the decision reflects a broader trend in Hollywood where studios decouple creation from direction to mitigate creative risks while preserving the core brand identity established by the original writer-director.

The financial stakes for this production are considerable, given the commercial trajectory of the first two films. "Smile" (2022) generated approximately $228 million in global box office revenue on a budget of roughly $17 million, while its sequel earned over $82 million worldwide. These figures demonstrate the viability of mid-budget horror as a profitable asset class for major studios. Investors are watching closely to see if the franchise can maintain this efficiency without the direct creative hand of its originator.

Key Takeaways

• David Bruckner will direct "Smile 3," with Nick Antosca writing the screenplay, replacing Parker Finn in those roles.
• Parker Finn remains involved as a producer, having previously pitched the initial framework for the third film.
• Paramount is leveraging the franchise's strong return on investment, which saw the first film gross $228 million globally.

Market analysts suggest that this hiring strategy serves as a hedge against the "auteur risk" often associated with horror franchises. By retaining Finn’s involvement in production, Paramount ensures continuity in the franchise’s tonal and thematic elements. This approach mirrors recent trends in the streaming era, where original creators are increasingly compensated for long-term IP stewardship rather than per-film direction fees. The studio’s commitment to the series underscores its reliance on proven horror formulas to drive theatrical attendance in a competitive landscape.

The production timeline has not yet been publicly disclosed, but development is expected to proceed through the first quarter of next year. Antosca and Bruckner are currently collaborating on the script, with a focus on expanding the mythology introduced in the precursor films. This expansion creates potential for higher production values, possibly pushing the budget beyond the initial $17 million model. Stakeholders will monitor the casting process for further indicators of the project’s scale and scope.

Ultimately, the hiring of Bruckner and Antosca represents a calculated risk for Paramount. While the franchise has demonstrated strong commercial performance, the departure of the original director from the helm is a notable shift. Success will depend on the new team’s ability to honor the source material while introducing fresh narrative elements. The industry will closely track the film’s reception as a benchmark for how studios balance creative ownership with commercial scalability in the current market environment.